.svg)
Dabur Research Foundation: Difference between revisions
>Tharun S Yadla (Dabur group template added) |
>ZI Jony m (v2.04b - Fix errors for CW project (Template contains useless word template:)) |
||
| Line 8: | Line 8: | ||
{{Infobox company | {{Infobox company | ||
| logo = Dabur Research Foundation | | logo = Dabur Research Foundation logo.png | ||
| name = Dabur Research Foundation | | name = Dabur Research Foundation | ||
| foundation = 1979 | | foundation = 1979 | ||
| Line 36: | Line 36: | ||
* [http://www.daburresearch.in/ Official website] | * [http://www.daburresearch.in/ Official website] | ||
{{ | {{Dabur Group}} | ||
{{Authority control}} | {{Authority control}} | ||
Revision as of 22:23, 12 August 2021
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
| File:Dabur Research Foundation logo.png | |
| Founded | 1979 |
|---|---|
| Headquarters | Sahibabad, Ghaziabad - 201010 (UP) , |
| Parent | Dabur India Limited |
| Website | daburresearch.in |
Dabur Research Foundation (DRF) is an Indian contract research organization offering pre-clinical services in drug discovery and development. It was established in 1979 to spearhead the research and development activities of Dabur, India's largest Ayurvedic medicine manufacturer.
References
- Articles about International Finance Corporation - Economic Times
- BioSpectrumIndia - the business of biotech - Customer relationships in a competitive market
- Elephant Capital buys stake in ClinTec Intl for Rs 58 cr
- Cosmetics testing kills 3.9 million animals - BioSpectrum Asia
- Burmans plan Rs 925-crore healthcare fund
- Dabur to re-expand its pharma research
Further reading
- Madaan, Alka; Singh, Pratibha; Awasthi, Anshumali; Verma, Ritu; Singh, Anu T.; Jaggi, Manu; Mishra, Shiva Kant; Kulkarni, Sadanand; Kulkarni, Hrishikesh (2012). "Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel". Clinical and Translational Oncology. 15 (1): 26–32. doi:10.1007/s12094-012-0883-2. PMID 22855169.
- Kumar, Vivek; Madaan, Alka; Sanna, Vinod K.; Vishnoi, Manupriya; Joshi, Narendra; Singh, Anu T.; Jaggi, Manu; Sharma, Pramod K.; et al. (2009). "Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives". Journal of Enzyme Inhibition and Medicinal Chemistry. 24 (5): 1169–78. doi:10.1080/14756360802696802. PMID 19555167.
- Bansal, Tripta; Jaggi, Manu; Khar, Roop K; Talegaonkar, Sushama (2009). "Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy". Journal of Pharmacy & Pharmaceutical Sciences. 12 (1): 46–78. CiteSeerX 10.1.1.557.474. PMID 19470292.
External links
 | This article about an organisation in India is a stub. You can help Wikipedia by expanding it. |